From October 1, 2019 to December 31, 2019, the company has repurchased 1,926,358 shares, representing 1.43% for $199.99 million. With this, the company has completed the repurchase of 62,469,704 shares, representing 41.19% for $4,261.35 million under the buyback announced on October 20, 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,492 GBX | -0.38% |
|
-1.10% | +2.98% |
11:14am | EQT Unit Invests in Biotechnology Company Asceneuron | MT |
07-15 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.98% | 79.32B | |
+63.05% | 856B | |
+38.98% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.87% | 244B | |
+4.99% | 234B | |
+16.24% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.